Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative ReviewArticle Published on 2022-10-012022-11-15 Journal: Clinical pharmacokinetics [Category] [DOI] 10.1007/s40262-022-01170-x PMC 바로가기
Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and PharmacodynamicsCOVID 폐렴에서 정맥내 나파모스타트 메실레이트의 무작위 대조 시험: 안전성, 약동학 및 약력학을 조사하기 위한 1b/2a상 실험 연구Clinical Trial Published on 2022-02-012022-09-11 Journal: EBioMedicine [Category] [DOI] 10.1016/j.ebiom.2022.103856 PMC 바로가기 [Article Type] Clinical Trial
Association between Nafamostat Mesylate and In-Hospital Mortality in Patients with Coronavirus Disease 2019: A Multicenter Observational StudyArticle Published on 2021-12-262022-10-30 Journal: Journal of Clinical Medicine [Category] [DOI] 10.3390/jcm11010116 PMC 바로가기 [Article Type] Article
Untapping host-targeting cross-protective efficacy of anticoagulants against SARS-CoV-2Review Published on 2021-10-282023-07-01 Journal: Pharmacology & therapeutics [Category] [DOI] 10.1016/j.pharmthera.2021.108027 PMC 바로가기 [Article Type] Review
Co-Spray Dried Nafamostat Mesylate with Lecithin and Mannitol as Respirable Microparticles for Targeted Pulmonary Delivery: Pharmacokinetics and Lung Distribution in RatsArticle Published on 2021-09-192022-10-28 Journal: Pharmaceutics [Category] [DOI] 10.3390/pharmaceutics13091519 PMC 바로가기 [Article Type] Article
Clinical efficacy of Nafamostat Mesylate in combination with Favipiravir for COVID-19 pneumonia treatment review articleReview Published on 2021-07-142022-10-04 Journal: Annals of Medicine and Surgery [Category] [DOI] 10.1016/j.amsu.2021.102560 PMC 바로가기 [Article Type] Review
Broad antiviral and anti‐inflammatory efficacy of nafamostat against SARS‐CoV‐2 and seasonal coronaviruses in primary human bronchiolar epitheliaResearch Article Published on 2021-06-302022-10-29 Journal: Nano Select [Category] [DOI] 10.1002/nano.202100123 PMC 바로가기 [Article Type] Research Article
Closing the portal to SARS-CoV-2 cellular entry: May open newer avenues…Comment Published on 2021-01-012023-07-12 Journal: Med Hypotheses [Category] [DOI] 10.1016/j.mehy.2020.110464 PMC 바로가기 [Article Type] Comment
Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapiesReview Published on 2020-12-012023-07-13 Journal: European Journal of Clinical Pharmacology [Category] [DOI] 10.1007/s00228-020-02963-4 PMC 바로가기 [Article Type] Review
Clinical improvement in a patient with severe coronavirus disease 2019 after administration of hydroxychloroquine and continuous hemodiafiltlation with nafamostat mesylateCase Reports Published on 2020-12-012023-07-13 Journal: Journal of infection and chemotherapy : official j [Category] [DOI] 10.1016/j.jiac.2020.08.001 PMC 바로가기 [Article Type] Case Reports